Responsible Side Effects Management in Oncology

Search for Predictors of Therapeutic Response in Ovarian Carcinoma

NCT01391351 ·Status: COMPLETED ·Phase: NA

Patient Reported Symptoms in Ovarian Cancer (PRECISION)

NCT01422265 ·Status: COMPLETED

A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer

NCT02591095 ·Status: COMPLETED ·Phase: PHASE2

Breast Cancer After Ovarian Cancer During and/or After Therapy: Genomic Evaluation

NCT05763472 ·Status: UNKNOWN

Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases

NCT01048814 ·Status: COMPLETED

The Analyses of Treatment Efficacy and Cost-effectiveness in Early-staged Ovarian Cancer Patients

NCT03019315 ·Status: UNKNOWN

Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer

NCT02125513 ·Status: UNKNOWN ·Phase: PHASE2

Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer Patients

NCT01124435 ·Status: COMPLETED ·Phase: PHASE2

Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer

NCT00660842 ·Status: UNKNOWN ·Phase: PHASE3

Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer

NCT00753545 ·Status: COMPLETED ·Phase: PHASE2

Dose-dense Chemotherapy Versus Intraperitoneal Chemotherapy as First-line Chemotherapy in Advanced Ovarian Cancer

NCT04135521 ·Status: COMPLETED

Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy

NCT03418844 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers

NCT04795596 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3

Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian Cancer

NCT01047891 ·Status: COMPLETED ·Phase: PHASE2

A Study of Docetaxel and Lobaplatin Versus Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian Cancer

NCT01851746 ·Status: UNKNOWN

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer

NCT05415709 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Role of the ATP7A Transporter in Ovarian Cancer

NCT05490407 ·Status: COMPLETED ·Phase: NA

Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma

NCT00429559 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Carboplatin-cyclophosphamide Combined With Atezolizumab

NCT02914470 ·Status: COMPLETED ·Phase: PHASE1

Optimize the Support of Patients in Pelvic Onco-gynecology Through Adapted Support Care in the Post-cancer Period. AFTERGYN Pilot Phase

NCT05731661 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer

NCT00003214 ·Status: COMPLETED ·Phase: PHASE3

Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer

NCT02408536 ·Status: UNKNOWN

Study on Decitabine Plus Carboplatin Versus Physician's Choice Chemotherapy in Recurrent, Platinum-resistant Ovarian Cancer.

NCT03467178 ·Status: UNKNOWN ·Phase: PHASE2

Improving Quality of Care for Patients With Recurrent Ovarian Cancer

NCT02809339 ·Status: UNKNOWN

Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer

NCT03598270 ·Status: COMPLETED ·Phase: PHASE3